Veterinary Medicines

ZOLETIL 100 (50 mg/ml+50 mg/ml) Liofilizado e solvente para solução injetável para cães e gatos

Authorised
  • Tiletamine hydrochloride
  • Zolazepam hydrochloride
Download as PDF

Product identification

Medicine name:
ZOLETIL 100 (50 mg/ml+50 mg/ml) Liofilizado e solvente para solução injetável para cães e gatos
Active substance:
  • Tiletamine hydrochloride
  • Zolazepam hydrochloride
Target species:
  • Dog
  • Cat
Route of administration:
  • Intramuscular and intravenous use

Product details

Active substance and strength:
  • Tiletamine hydrochloride
    50.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Zolazepam hydrochloride
    50.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Lyophilisate for solution for injection
Withdrawal period by route of administration:
  • Intramuscular and intravenous use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN01AX99
Legal status of supply:
  • Medicinal product subject to medical prescription
Authorisation status:
  • Valid
Authorised in:
  • Portugal
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
  • VIRBAC
Responsible authority:
  • Directorate General For Food And Veterinary
Authorisation number:
  • 51641
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Portuguese (PDF)
Published on: 11/05/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."